Human retrovirus research: HTLV-1
This page covers Dustin Edwards's earlier research on human retroviruses, on human T-cell leukemia virus type 1 (HTLV-1). Each published paper, chapter and conference abstract has a short plain-language summary of what it found, a link to its page on this site and a link to its DOI. The papers are grouped by theme, then listed by year. It is written for students and for anyone curious about the work; the papers themselves have the full detail. His current retrovirus work, on viruses of wild birds, is on the avian retroviruses page.
HTLV-1 in brief#
HTLV-1 is a retrovirus that infects T cells, a type of white blood cell. Most people who carry it never become ill, but it causes adult T-cell leukemia (ATL), an aggressive cancer that is hard to treat with chemotherapy. Like every retrovirus, HTLV-1 inserts a DNA copy of its genome into the chromosomes of the cells it infects, so an infected person carries it for life. The 3′ end of its genome holds several overlapping genes for small regulatory and accessory proteins: Tax, the protein that drives cancer, and the products of two reading frames called orf-I and orf-II, the proteins p12, p8, p13 and p30.
What the work showed#
Taken together, this work helped explain how HTLV-1 persists in the body for decades. The accessory proteins p12, p8 and p30 do several jobs for the virus: they change calcium levels inside the cell, adjust the signals a T cell receives through its T-cell receptor, reduce the display of viral pieces that lets the immune system recognize infected cells, and hold the viral tax and rex messenger RNAs in the nucleus. The virus does not need these proteins to grow in cells in a dish, but it does need them to set up and keep a long-term infection in a living host.
Tax turns up the gene for PCNA, a protein involved in copying and repairing DNA, and in doing so can interfere with DNA repair, which may help explain the genetic instability of HTLV-1-infected cells. And blocking an enzyme called geranylgeranyl transferase lowered the survival of HTLV-1-transformed cells in a way that did not depend on the tumor suppressor p53, which points to a possible route for treatment.
Publications by theme#
Each entry links to its page on this site, which has the full citation, the abstract and, where one can be shared, the PDF. The full list of papers across every research area is on the publications page.
Tax and cell transformation#
- 2008. A complex of cell proteins binds a newly identified site in the PCNA promoter and acts as a brake on the gene, and Tax stops that complex from forming, which raises the promoter's activity. More PCNA can mean less of one kind of DNA repair, which could contribute to the genetic instability seen in infected cells. Human T-Cell Leukemia Virus Type 1 Tax Relieves Repression of Proliferating Cell Nuclear Antigen Gene Expression, Journal of Virology. DOI: 10.1128/jvi.00356-08
- 2011. GGTI-298, a drug that blocks the enzyme geranylgeranyl transferase-I, lowered the survival of HTLV-1-transformed cells and stalled them at a late stage of the cell cycle (G2/M) without reactivating p53. It also reduced activity of the viral promoter, lowered Tax levels and dampened NF-kappaB, a survival signal in these cells, which suggests this enzyme helps keep transformed cells alive. Inhibition of Geranylgeranyl Transferase-I Decreases Cell Viability of HTLV-1-Transformed Cells, Viruses. DOI: 10.3390/v3101815
The orf-I and orf-II proteins: p12, p8, p13 and p30#
The orf-I reading frame makes p12, which can be cut to make p8. The orf-II reading frame makes p13 and p30.
- 2011. A conference abstract on how pairing up (dimerization) and the attachment of a fatty acid (palmitoylation) affect what p12 and p8 do, the early form of the 2014 Journal of Virology paper below. Role of dimerization and palmitoylation on the function of HTLV-1 p12 and p8, Retrovirology (conference supplement). DOI: 10.1186/1742-4690-8-s1-a124
- 2014. p30 dampens the interferon response of monocytes and dendritic cells when they are stimulated through Toll-like receptors 3 and 4, while p12 and p8 do not. A virus engineered without p30 was poorer at this and less infectious, which helps explain why the virus needs p30 in a living host. Human T-Cell Leukemia/Lymphoma Virus Type 1 p30, but Not p12/p8, Counteracts Toll-Like Receptor 3 (TLR3) and TLR4 Signaling in Human Monocytes and Dendritic Cells, Journal of Virology. DOI: 10.1128/jvi.01788-13
- 2014. p12 and p8 pair up through a shared cysteine at position 39, and only the unpaired forms carry an attached fatty acid. Changing that cysteine stopped both the pairing and the fatty acid, yet p8 still reached the cell surface, still made cells stick together and still helped the virus spread. Palmitoylation and p8-Mediated Human T-Cell Leukemia Virus Type 1 Transmission, Journal of Virology. DOI: 10.1128/jvi.03444-13
- 2014. Natural differences in orf-I change how much p12 and how much p8 a virus makes, and infected people whose virus made both in balance tended to carry more viral DNA. Viruses engineered to make mostly one protein or the other spread poorly in macaques, so the virus appears to need both. Co-dependence of HTLV-1 p12 and p8 Functions in Virus Persistence, PLoS Pathogens. DOI: 10.1371/journal.ppat.1004454
- 2014. The conference talk that presented that finding. Both orf-I isoforms, p12 and p8, are required for efficient HTLV-1 infection and persistence, Retrovirology (conference supplement). DOI: 10.1186/1742-4690-11-s1-o13
The related simian virus STLV-3#
Simian T-cell lymphotropic virus type 3 (STLV-3) is a virus of monkeys that is nearly identical to HTLV-3, the most recently discovered human member of the family. Because no HTLV-3-infected cell line exists, STLV-3 is the way to study what that branch of the family encodes.
- 2015. Three previously unknown viral messenger RNAs were found in STLV-3, along with one reported earlier, and the small proteins they encode were located inside the cell. Two of them held back viral gene expression, and none of them transformed cells on its own, while Tax and the antisense protein of HTLV-3 did. Discovery and Characterization of Auxiliary Proteins Encoded by Type 3 Simian T-Cell Lymphotropic Viruses, Journal of Virology. DOI: 10.1128/jvi.02150-14
The HTLV-1 molecular epidemiology database#
- 2012. A public, searchable database that gathers published HTLV-1 sequences and annotates them with the clinical and geographic information reported alongside them, so researchers can study where variants of the virus occur and how they relate to disease. A Public HTLV-1 Molecular Epidemiology Database for Sequence Management and Data Mining, PLoS ONE. DOI: 10.1371/journal.pone.0042123
Reviews and chapters#
- 2007. A chapter on RNA tumor viruses, using HTLV-1 as the model: its Tax protein acts on the controls of cell division and DNA repair, and that is how the virus transforms cells. RNA Tumour Viruses, The Cancer Handbook. DOI: 10.1002/9780470025079.chap06.pub2
- 2011. A review of what was then known about the orf-I products p12 and p8 and the orf-II products p13 and p30: how they are made from spliced messenger RNAs, and their reported effects on gene expression, cell death, host cell activation, infectivity, transmission and immune responses. The review makes the central point that these proteins are not required for the virus to replicate in cell culture but do matter for infection in a living host. Orf-I and Orf-II-Encoded Proteins in HTLV-1 Infection and Persistence, Viruses. DOI: 10.3390/v3060861
HTLV-1 coinfection poster#
One conference poster, listed under Publications by its published title, concerned regulatory proteins in coinfection. No abstract was published with it, so it is listed here by title only, with no summary of findings.
- 2014. Role of regulatory proteins in HIV-1/HTLV-1 coinfection, Retrovirology (conference supplement). DOI: 10.1186/1742-4690-11-s1-p122